ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution

BOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Hello Heart, the digital leader in preventive heart health, is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform.

Amwell health plan clients can now offer their employer accounts the Hello Heart cardiovascular solution to eligible members and employees with high blood pressure, high cholesterol, or other risk factors for cardiovascular disease. Members can easily access the Hello Heart solution from their current Amwell-powered offering. In addition, members will have access to virtual primary care, urgent care, behavioral health and other clinical program offerings.

Heart disease is the number one cause of death in the U.S. and among the most expensive health conditions to treat, costing health plans an average of $12,500 per member per year. High blood pressure is a known risk factor for heart disease affecting almost half of U.S. adults.

Members who sign up for the digital heart health program will receive a connected blood pressure monitor and access to an app that provides personalized daily coaching and tracks key metrics to help them better manage their heart health. Also, clinicians can receive a member's results and make data-driven recommendations about their care.

“The widespread clinical and financial burden of heart disease is skyrocketing. Health plans and employers need a solution to address this crisis at scale,” said Edo Paz, M.D., senior vice president, Medical Affairs at Hello Heart. “As the market leader for preventive heart health management, Hello Heart can help organizations drive better outcomes and lower costs for large populations at risk of cardiovascular disease. We look forward to supporting the heart health of many more people as part of Amwell’s hybrid care delivery platform.”

Amwell’s clinical programs portfolio is integrated into the Amwell Converge platform and features virtual and digital care products from innovative partners addressing various health conditions. The unified ecosystem provides health plans with the technology to offer employers and their members a seamless entry point to access many solutions, creating a personalized, cost-effective, whole-person care model focused on improved clinical outcomes and driving efficiencies. Click here to learn more about the Hello Heart program available in the Amwell clinical portfolio for health plan clients.

“Our comprehensive solution is dependable, safe and secure, with a proven track record of integrating and scaling effectively. It powers a large part of the U.S. healthcare ecosystem and facilitates the exchange of data and services across our client base to make care even more efficient and accessible,” said Ido Schoenberg, M.D., CEO of Amwell. “We are delighted to include Hello Heart as our latest portfolio partner, as the company seeks to provide healthcare organizations with digital and automated support that can prevent or reverse the health and financial burdens caused by heart disease.”

Hello Heart and Amwell are sponsoring the HLTH conference Oct. 20-23 in Las Vegas. Hello Heart will demonstrate its digital cardiovascular health program in booth #2133. Amwell leaders will be in booth #5036, highlighting how Hello Heart integrates into the company’s broader clinical care portfolio.

About Hello Heart‍
Hello Heart is on a mission to change the way people care for their hearts. The company provides the first app and connected heart monitor to help people track and manage their heart health and get real-time tips. With Hello Heart, people can take steps to control their risk of heart attacks and strokes – the leading cause of death in the United States. Peer-reviewed studies show that high-risk users of Hello Heart have seen meaningful drops in blood pressure, cholesterol and even weight. Recognized as the digital leader in preventive heart health, Hello Heart is trusted by more than 120 leading Fortune 500 and government employers, national health plans, and labor organizations such as 3M, Lenovo, Northwestern Mutual, the City of Fort Worth, and the Cleveland Bakers and Teamsters Pension Fund. Hello Heart clients can save $1,676 per enrolled user annually according to a third-party analysis by the Validation Institute.

Founded in 2013, Hello Heart has raised more than $138 million from top venture firms like Khosla Ventures, IVP, and Stripes, and has been featured in The Washington Post, CNBC, CBS Evening News, and NPR. Hello Heart is a best-in-class solution on the American Heart Association’s Innovators’ Network, CVS Health Point Solutions Management offering, and many other health solution platforms. Visit www.helloheart.com for more information.

About Amwell
Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single comprehensive platform to support all digital health needs, from urgent to acute and post-acute care, chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.   

©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell Converge™, Carepoint™ and the Amwell logo are registered trademarks of American Well Corporation.


For more information

Hello Heart Media
Andrew Padgett
Media@helloheart.com

Amwell Media
Angela Vogen
Press@amwell.com

Amwell Investors
Sue Dooley
Sue.Dooley@amwell.com

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.